Progresos y promesas en melanoma

Cinat, Gabriela.
Rev. argent. cancerol ; 42(3): 9-11, 2014.
Artículo en Español | LILACS | ID: lil-770792

Documentos relacionados

  1. Converting Cold into Hot Tumors by Combining Immunotherapies.
  2. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.
  3. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
  4. Immune Checkpoint Blockade across the Cancer Care Continuum.
  5. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
  6. Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
  7. Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world study.
  8. Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma.
  9. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
  10. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.